Literature DB >> 27826059

Serum HBV pgRNA as a clinical marker for cccDNA activity.

Katja Giersch1, Lena Allweiss1, Tassilo Volz1, Maura Dandri2, Marc Lütgehetmann3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27826059     DOI： 10.1016/j.jhep.2016.09.028

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  44 in total

Review 1.  Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs.

Authors:  Fengmin Lu; Jie Wang; Xiangmei Chen; Dongping Xu; Ningshao Xia
Journal:  Front Med       Date:  2017-11-23       Impact factor: 4.592

2.  Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.

Authors:  Ni Lin; Aizhu Ye; Jinpiao Lin; Can Liu; Jinlan Huang; Ya Fu; Songhang Wu; Siyi Xu; Long Wang; Qishui Ou
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

3.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

4.  Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

Authors:  Yuhua Gao; Yutang Li; Qinghua Meng; Zhanqing Zhang; Ping Zhao; Qinghua Shang; Yue Li; Mingze Su; Tong Li; Xueen Liu; Hui Zhuang
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

Review 5.  Therapeutic Advances in Viral Hepatitis A-E.

Authors:  Navroop Nagra; Richard A Kozarek; Blaire E Burman
Journal:  Adv Ther       Date:  2022-02-27       Impact factor: 3.845

6.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

7.  Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B.

Authors:  Fa-Da Wang; Jing Zhou; Lan-Qing Li; Meng-Lan Wang; Ya-Cao Tao; Yong-Hong Wang; Dong-Mei Zhang; En-Qiang Chen
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

8.  Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a.

Authors:  Minghui Li; Lu Zhang; Yao Lu; Qiqi Chen; Huihui Lu; Fangfang Sun; Zhan Zeng; Gang Wan; Linqing Zhao; Yao Xie
Journal:  Virol Sin       Date:  2020-09-25       Impact factor: 4.327

Review 9.  Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection.

Authors:  Shi Liu; Bin Zhou; Juan D Valdes; Jian Sun; Haitao Guo
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

10.  Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed.

Authors:  Harel Dahari; Amir Shlomai; Scott J Cotler
Journal:  J Viral Hepat       Date:  2021-01-15       Impact factor: 3.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.